Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Zimmer revises Biomet bid for EU regulators
Zimmer today said it further revised the terms of its $13.35 billion bid for Biomet in an effort to satisfy anti-trust regulators on the European Commission.
It’s the 2nd attempt by the Warsaw, Ind.-based rivals to mollify the EU about the deal, announced last April, a union that would bring together 2 of the biggest names in orthopedics. Read more
2. JenaValve taps medtech vet Keltjens for interim CEO
JenaValve tapped a medtech veteran with a string of successful exits behind him as interim chairman & CEO, replacing another medical device vet, David Drachman, after just 7 months.
Drachman, who spent 10 years in the corner office at AtriCure (NSDQ:ATRC), “resigned from the company for non-business related personal reasons, JenaValve said. Read more
1. Ex-NFL great Gault must face SEC fraud charges
Willie Gault, the ex-NFL wide receiver who played for the Chicago Bears and Los Angeles Raiders, can’t shake a case against him alleging he played a role in a 5-year fraud scheme to inflate the share price at a heart monitor device company.
A federal judge in California refused to throw out 3 U.S. Securities & Exchange Commission claims against Gault. The football great, along with Heart Tronics/Signalife ex-outside counsel Mitchell Stein and others, is charged with illegally pumping up the company’s stock price. Read more
